drugset / Trial / NCT00328458
EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients
Phase 1
Completed
39 enrolled
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Novartis Pharmaceuticals · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety of the drug EPO906 that could shrink tumors when used with radiation therapy in cancer patients.
Timeline
- Start
- 2004-02
- Primary completion
- 2008-05
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Patupilone | Small molecule | — | Intravenous |